Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancer.

Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancer.
复制标题

蛋白激酶C δ调节单核吞噬细胞并阻碍癌症免疫治疗的反应。

DOI:
10.1126/sciadv.add3231
复制
发表时间:
2023-12-22
期刊:
影响因子:
13.6
通讯作者:
--
中科院分区:
综合性期刊1区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

单核巨噬细胞(MPS)在组织内稳态中起着至关重要的作用;然而,MPS也有助于肿瘤的进展和对免疫检查点阻断(ICB)的抵抗。靶向MPS可能是提高ICB疗效的有效策略。我们报道了蛋白激酶C增量(PKCδ)是一种丝氨酸/苏氨酸激酶,在人和小鼠肿瘤中由MPS大量表达。与野生型相比,pkcδ−/−小鼠的肿瘤进展速度较慢,对抗PD-1抗体的反应增强。来自pkcδ−/−小鼠的肿瘤表现出th1偏斜的免疫反应,包括抗原呈递增加和T细胞激活。体内MPS的耗尽改变了对照组小鼠的肿瘤生长,但不改变PKCδ−/−小鼠的肿瘤生长。与pKCδ−/−+/+对照相比,pKCδM2样巨噬细胞与肿瘤细胞共注射入野生型小鼠可显著延缓肿瘤生长,并显著增加瘤内T细胞的活化。PKCδ缺陷通过激活I型和II型干扰素信号使MPS重新编程。因此,PKCδ可能被靶向重新编程MPS以增强ICB的疗效。PKCδ是一种先天免疫检查点,可促进癌症的免疫抑制。
Mononuclear phagocytes (MPs) play a crucial role in tissue homeostasis; however, MPs also contribute to tumor progression and resistance to immune checkpoint blockade (ICB). Targeting MPs could be an effective strategy to enhance ICB efficacy. We report that protein kinase C delta (PKCδ), a serine/threonine kinase, is abundantly expressed by MPs in human and mouse tumors. PKCδ−/− mice displayed reduced tumor progression compared to wild types, with increased response to anti–PD-1. Tumors from PKCδ−/− mice demonstrated TH1-skewed immune response including increased antigen presentation and T cell activation. Depletion of MPs in vivo altered tumor growth in control but not PKCδ−/− mice. Coinjection of PKCδ−/− M2-like macrophages with cancer cells into wild-type mice markedly delayed tumor growth and significantly increased intratumoral T cell activation compared to PKCδ+/+ controls. PKCδ deficiency reprogrammed MPs by activating type I and type II interferon signaling. Thus, PKCδ might be targeted to reprogram MPs to augment ICB efficacy. PKCδ is an innate immune checkpoint that promotes immune suppression in cancer.
DOI: 10.1093/nar/gkaa1113
发表时间: 2021-01-08
影响因子: 14.9
作者:
Gene Ontology Consortium
通讯作者: Gene Ontology Consortium
DOI: 10.1093/bioinformatics/btw313
发表时间: 2016-09-15
期刊: BIOINFORMATICS
影响因子: 5.8
作者:
Gu, Zuguang;Eils, Roland;Schlesner, Matthias
通讯作者: Schlesner, Matthias
DOI: 10.1038/s41467-021-22033-2
发表时间: 2021-03-19
影响因子: 16.6
作者:
Alicea-Torres K;Sanseviero E;Gui J;Chen J;Veglia F;Yu Q;Donthireddy L;Kossenkov A;Lin C;Fu S;Mulligan C;Nam B;Masters G;Denstman F;Bennett J;Hockstein N;Rynda-Apple A;Nefedova Y;Fuchs SY;Gabrilovich DI
通讯作者: Gabrilovich DI
DOI: 10.1016/j.cell.2019.02.005
发表时间: 2019-04-18
期刊: CELL
影响因子: 64.5
作者:
Binnewies, Mikhail;Mujal, Adriana M.;Krummel, Matthew F.
通讯作者: Krummel, Matthew F.
DOI: 10.1038/sj.onc.1209065
发表时间: 2006-01-01
期刊: ONCOGENE
影响因子: 8
作者:
D'Costa, AM;Robinson, JK;Denning, MF
通讯作者: Denning, MF